Gryphon Financial Partners LLC Edwards Lifesciences Corp Transaction History

Gryphon Financial Partners LLC

$665 Million
Q2 2024

A detailed history of Gryphon Financial Partners LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Gryphon Financial Partners LLC holds 4,685 shares of EW stock, worth $306,773. This represents 0.06% of its overall portfolio holdings.

Number of Shares

4,685

Previous 5,142 8.89%

Holding current value

$306,773

Previous $491,000 12.02%

% of portfolio

0.06%

Previous 0.08%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$84.3 - $94.31 $38,525 - $43,099	-457 Reduced 8.89%	4,685 $432,000
Q1 2024 May 01, 2024	SELL	$72.54 - $95.56 $95,172 - $125,374	-1,312 Reduced 20.33%	5,142 $491,000
Q4 2023 Feb 06, 2024	BUY	$61.71 - $77.76 $104,783 - $132,036	1,698 Added 35.7%	6,454 $492,000
Q3 2023 Nov 07, 2023	BUY	$69.28 - $93.38 $237,768 - $320,480	3,432 Added 259.21%	4,756 $329,000
Q2 2023 Aug 08, 2023	SELL	$81.41 - $94.33 $294,378 - $341,097	-3,616 Reduced 73.2%	1,324 $124,000
Q1 2023 May 03, 2023	BUY	$74.26 - $84.51 $371 - $422	5 Added 0.1%	4,940 $408,000
Q4 2022 Feb 08, 2023	BUY	$68.3 - $87.44 $10,723 - $13,728	157 Added 3.29%	4,935 $368,000
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $13,591 - $17,702	-165 Reduced 3.34%	4,778 $395,000
Q2 2022 Jul 28, 2022	BUY	$86.5 - $128.27 $31,572 - $46,818	365 Added 7.97%	4,943 $470,000
Q1 2022 May 05, 2022	SELL	$101.96 - $128.34 $71,168 - $89,581	-698 Reduced 13.23%	4,578 $538,000
Q4 2021 Feb 01, 2022	SELL	$106.37 - $130.68 $43,505 - $53,448	-409 Reduced 7.19%	5,276 $684,000
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $58,761 - $70,090	-571 Reduced 9.13%	5,685 $643,000
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $10,563 - $13,199	126 Added 2.06%	6,256 $520,000
Q1 2021 May 05, 2021	SELL	$78.68 - $90.67 $1,416 - $1,632	-18 Reduced 0.29%	6,130 $512,000
Q4 2020 Feb 10, 2021	SELL	$71.69 - $91.23 $788 - $1,003	-11 Reduced 0.18%	6,148 $561,000
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $1,612 - $2,098	-24 Reduced 0.39%	6,159 $492,000
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $206,050 - $275,557	3,581 Added 137.62%	6,183 $428,000
Q1 2020 May 05, 2020	SELL	$52.41 - $81.0 $10,219 - $15,795	-195 Reduced 6.97%	2,602 $491,000
Q4 2019 Feb 06, 2020	BUY	$71.7 - $82.09 $1,147 - $1,313	16 Added 0.58%	2,797 $653,000
Q3 2019 Nov 07, 2019	SELL	$61.55 - $75.43 $3,323 - $4,073	-54 Reduced 1.9%	2,781 $611,000
Q2 2019 Aug 09, 2019	SELL	$55.74 - $64.41 $2,006 - $2,318	-36 Reduced 1.25%	2,835 $524,000
Q4 2018 Feb 11, 2019	SELL	$46.41 - $56.94 $2,506 - $3,074	-54 Reduced 1.85%	2,871 $440,000
Q3 2018 Nov 06, 2018	BUY	$45.7 - $58.03 $123,207 - $156,448	2,696 Added 1177.29%	2,925 $509,000
Q1 2018 May 14, 2018	SELL	$37.19 - $47.45 $520 - $664	-14 Reduced 5.76%	229 $32,000
Q4 2017 Feb 09, 2018	BUY	$33.79 - $39.39 $8,210 - $9,571	243	243 $27,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gryphon Financial Partners LLC with notifications on news.

Account

Gryphon Financial Partners LLC Edwards Lifesciences Corp Transaction History